Diane Goldblum Graff
Psychiatric/Mental Health, Adult · Linwood, NJNPI 1154449734
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $667 and has fallen 97.6% since, to $16 in 2025. Among psychiatric/mental health, adult clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$301
- AbbVie$265
- Idorsia Pharmaceuticals US Inc$209
- Otsuka America Pharmaceutical, Inc.$139
- Lundbeck LLC$126
- Neurocrine Biosciences, Inc.$120
- plus $399 from 12 others
What the payments were for
- Food & beverage$1,559100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUVIVIQ$120
How this compares
$1,559 in reported general payments places this provider in the 90th percentile of 35 psychiatric/mental health, adult providers in New Jersey.
See all psychiatric/mental health, adult providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 11 | $3,379 |
| Lisdexamfetamine Dimesylate | 11 | $2,568 |
| Aripiprazole | 24 | $743 |
| Sertraline Hcl | 22 | $467 |
| Alprazolam | 55 | $448 |
| Escitalopram Oxalate | 24 | $432 |
| Fluoxetine Hcl | 21 | $395 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $387 |
| Olanzapine | 11 | $348 |
| Bupropion Hcl SrBupropion Hcl | 16 | $341 |
| Quetiapine Fumarate | 38 | $306 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $221 |
| Lamotrigine | 32 | $201 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $182 |
| Clonazepam | 52 | $175 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health, adult in Linwood
- Elaine KunigonisLinwood$412
- Frances BurnsLanoka Harbor$10K
- Jennifer Minnick-BrennanShrewsbury$5K
- Mary DesaneTinton Falls$2K
- Susan EganUpper Montclair$1K
- Barbara WrenVoorhees$1K
- Ann RhaticanCedar Knolls$1K
- Andrea CochranVoorhees$1K
- Susan FranklinGalloway$776
- Karen MoosviColts Neck$642
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.